El objetivo del estudio fue determinar la actividad antioxidante y antimicrobiana del extracto etanólico de las partes aéreas de la especie Solanum radicans L.f. (huallpachaqui) procedente de San Juan de Chacña, provincia de Aymaraes, departamento de Apurímac. El extracto se llevó a sequedad, se fraccionó y determinó la presencia de metabolitos secundarios por reacciones de precipitación y/o coloración; se efectuó la caracterización del extracto mediante determinación de pH, sólidos totales, sólidos solubles, cenizas, color y aspecto. La actividad antioxidante fue evaluada por el método de inhibición del radical 2,2-difenil- 1-picrilhidrazil (DPPH) y el método del Poder Antioxidante de Reducción Férrica (FRAP); la actividad antimicrobiana se probó en cepas de Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa y Proteus mirabilis. Se identificó presencia ...

El sector agrícola enfrenta riesgos por los daños causados por fitopatógenos, y muchos agricultores dependen de fungicidas sintéticos para combatirlos. Sin embargo, el uso excesivo de estos productos contamina el ambiente y favorece la resistencia de los patógenos. Este estudio evaluó la inhibición del crecimiento micelial de 57 extractos vegetales sobre Botrytis cinerea, Lasiodiplodia theobromaey Fusariumsp., y su eficacia en el control de Erysiphe necatoren campo, además de su efecto fitotóxico en semillas de trigo y la identificación de metabolitos presentes en los extractos. Los extractos más efectivos fueron los de Ambrosia artemisiifolia, Conyza sumatrensis, Dysphania ambrosioides, Minthostachis mollis, Salvia sp., Pimpinella anisumy Syzygium aromaticum. El extracto de P. anisumpresentó la mayor inhibición del crecimiento de B. cinereaen tomates, mientras que para el c...

“This is a review of the current status of drug bioequivalence studies in Peru. A bibliographic search was conducted in PubMed (Medline database) for bioequivalence studies in Peru. Generic drugs constitute the basis of pharmacological requests in health care systems in Latin American countries. Peru has enacted laws and regulations that require bioequivalence studies of high health risk drugs and exemptions, based on international legislation, to be conducted in research centers accredited by the authority of Health. There is a list of 19 drugs that must demonstrate their therapeutic equivalence through in vivo or in vitro studies, of which 13 have shown bioequivalence in vivo, and 8 of those have shown bioequivalence in vitro. There is a challenge for health authorities to enforce the current legislation and an even greater challenge for pharmaceutical laboratories to demonstrate bio...

Introduction: Innovative and similar branded medications are expensive and are not accessible in the poorest sectors of Peru, hence the importance of having bioequivalent generic medications. This study aims to evaluate the in vitro biopharmaceutical quality of risperidone 2-mg tablets and their impact on public health. Methods: Four brands of risperidone from the local market were studied (two generic [G1T, G2A], one similar [M1], and one reference [R1]). An analytical and experimental study was conducted using a spectrophotometric method for the dissolution profile in a United States Pharmacopeia (USP) apparatus 2 at 50 rpm with 500 mL of dissolution medium at pH 1.2, 4.5, and 6.8, at 37 ± 0.5 °C. Weight, hardness, and friability were also evaluated. Similarity factor (f2), dissolution efficiency, and mean dissolution time were used as statistical indicators of biopharmaceutical qual...

HIGH-FLOW NON-INVASIVE VENTILATION (NIV) DEVICES REDUCE THE MORBIDITY AND MORTALITY OF COVID-19. THE OBJECTIVE WAS TO EVALUATE THE USE OF THE NON-INVASIVE VENTILATION DEVICE WITH HIGH-FLOW HELMET CPAP DESIGNED IN PERU IN PATIENTS WITH SEVERE ACUTE RESPIRATORY SYNDROME (COVID-19) HOSPITALIZED IN THE EMERGENCY SERVICES OF FIVE HOSPITALS. PROSPECTIVE MULTICENTER AND CROSS-SECTIONAL OBSERVATIONAL STUDY FROM FIVE HOSPITALS FROM JULY TO AUGUST 2020. 19 PATIENTS WERE RECRUITED AND DIVIDED INTO TWO GROUPS (G-1 N = 10; G-2 N = 9) APPLYING CLINICAL AND GASOMETRIC PARAMETERS AS INDICATORS OF DISEASE EVOLUTION UPON HOSPITAL ADMISSION AND WITHIN 24 HOURS. A PROGRESSIVE INCREASE IN THESE PARAMETERS WAS OBSERVED IN THOSE PATIENTS WHO USED THE NIV CPAP HELMET WITHIN THE FIRST 24 HOURS. IN G-01, IMPROVEMENT WAS EVIDENT IN 90% (N = 9/10): PAO2 (RANGE 48–137; AVERAGE: 82.49 ± 8.07; P-VALUE = 0.008), CO2...

High-flow non-invasive ventilation (NIV) devices reduce the morbidity and mortality of COVID-19. The objective was to evaluate the use of the non-invasive ventilation device with high-flow helmet CPAP designed in Peru in patients with severe acute respiratory syndrome (COVID-19) hospitalized in the emergency services of five hospitals. Prospective multicenter and cross-sectional observational study from five hospitals from July to August 2020. 19 patients were recruited and divided into two groups (G-1 n = 10; G-2 n = 9) applying clinical and gasometric parameters as indicators of disease evolution upon hospital admission and within 24 hours. A progressive increase in these parameters was observed in those patients who used the NIV CPAP helmet within the first 24 hours. In G-01, improvement was evident in 90% (n = 9/10): PaO2 (range 48–137; average: 82.49 ± 8.07; p-value = 0.008), CO2...

Heliotropium arborescens (Galán de Mera et al. 2022) is a herbaceous plant that contains various biophenolic compounds that exhibit antibacterial property and antioxidant activity that could prevent diseases caused by free radicals. The objective was to study the biophenolic compounds and metal ions associated with the in vitro antioxidant and antibacterial activity of the ethanolic extract of Heliotropium arborescens L. leaves from the Andean region of Ayacucho-Peru. The total polyphenolic content (TPC) was determined by the Folin-Ciocalteu method; Total flavonoid content (TFC) was determined by spectrophotometry at 510 nm, TFC was expressed in mg quercetin/g sample (mg QE/g). Antioxidant activity by three in vitro methods; determination of metals by flame atomic absorption spectrophotometry (FAAS) and antibacterial activity by agar diffusion method. The values ​​obtained from the ...

Context: Acute inflammation due to persistent stimulation of noxes evolves into chronic inflammation that contributes to the pathogenesis of asthma, arthritis, atherosclerosis, diabetes, aging, and cancer; therefore, it is justified to study plants with anti-inflammatory activity and fewer adverse effects. Aims: To evaluate the potential anti-inflammatory effect of the total flavonoid content of the hydroalcoholic extract of the leaves of Senna alata (L.) Roxb (HELSA) in an experimental model of acute inflammation induced by carrageenan in rats. Methods: The total flavonoid content (TFC) was determined by spectrophotometry at 510 nm, total polyphenolic content (TPC) by the Folin-Ciocalteu method, and antioxidant activity by two in vitro methods. The oral median lethal dose (LD50) was determined by the logarithmic method, and acute inflammation was induced by 1% carrageenan in rats. Resul...

The CYP1A1 isoenzyme is responsible for the biotransformation of procarcinogens, such as Benzo(a)pyrene, into reactive metabolites. Meanwhile, GSTM1 facilitates the detoxification of these metabolites by conjugating them with glutathione. The presence of the CYP1A1*2A genetic variant intensifies the production of these reactive metabolites, and the deletion of the GSTM1 gene (GSTM1*0) impairs their detoxification. This enzymatic imbalance leads to the formation of DNA adducts, which are known to contribute to cancer and other diseases. Given the importance of studying these genes within the framework of 4P medicine (predictive, preventive, personalized, and participatory), the primary objective of this study was to investigate the prevalence of GSTM1*0 and CYP1A1*2A in the central Peruvian coastal Population as genetic biomarkers. The study included 131 individual residents of the Peruvi...

The CYP1A1 isoenzyme is responsible for the biotransformation of procarcinogens, such as Benzo(a)pyrene, into reactive metabolites. Meanwhile, GSTM1 facilitates the detoxification of these metabolites by conjugating them with glutathione. The presence of the CYP1A1*2A genetic variant intensifies the production of these reactive metabolites, and the deletion of the GSTM1 gene (GSTM1*0) impairs their detoxification. This enzymatic imbalance leads to the formation of DNA adducts, which are known to contribute to cancer and other diseases. Given the importance of studying these genes within the framework of 4P medicine (predictive, preventive, personalized, and participatory), the primary objective of this study was to investigate the prevalence of GSTM1*0 and CYP1A1*2A in the central Peruvian coastal Population as genetic biomarkers. The study included 131 individual residents of the Peruvi...

The major production of artisanal and industrial wines is elaborate in the Ica Valley, Peru. The objective was to evaluate the antioxidant activity of polyphenols and permissible values of glyphosate in artisanal wines from the Pisco Routes of the Ica Valley, Peru. Samples: six coded artisanal wines and two commercial brands as references (60088 and 60089). Total polyphenol content (TPC) was found between 107.90 ± 0.30 (60091) and 234.73 ± 0.61 mg GAE/100 mL (60084); total flavonoid content (TFC) was between 9.70 ± 0.30 (60091) and 16.83 ± 0.25 mg QE/100 mL (60084). Antioxidant activity: DPPH between 34.9 ± 0.44 (60091) and 55.6 ± 0.30 mM TEAC/100 mL (60085). FRAP between 42.50 ± 0.36 (60091) and 117.3 ± 0.44 (60085). Correlation relationship: TPC/DPPH (mM TEAC/100 mL) for 60086 (r = 0.7302, R2 = 0.5332), 60091 (r = 0.8029, R2 = 0.6447), 60085 (r = -0.9820, R2 = 0.9643), and for ...

The major production of artisanal and industrial wines is elaborate in the Ica Valley, Peru. The objective was to evaluate the antioxidant activity of polyphenols and permissible values of glyphosate in artisanal wines from the Pisco Routes of the Ica Valley, Peru. Samples: six coded artisanal wines and two commercial brands as references (60088 and 60089). Total polyphenol content (TPC) was found between 107.90 ± 0.30 (60091) and 234.73 ± 0.61 mg GAE/100 mL (60084); total flavonoid content (TFC) was between 9.70 ± 0.30 (60091) and 16.83 ± 0.25 mg QE/100 mL (60084). Antioxidant activity: DPPH between 34.9 ± 0.44 (60091) and 55.6 ± 0.30 mM TEAC/100 mL (60085). FRAP between 42.50 ± 0.36 (60091) and 117.3 ± 0.44 (60085). Correlation relationship: TPC/DPPH (mM TEAC/100 mL) for 60086 (r = 0.7302, R2 = 0.5332), 60091 (r = 0.8029, R2 = 0.6447), 60085 (r = -0.9820, R2 = 0.9643), and for ...

Background/Objectives: Epilepsy is characterized by recurrent, unprovoked, self-limiting seizures of genetic, acquired, or unknown origin. It affects more than 50 million people worldwide. The prevalence in Peru is 11.9–32.1 per 1000 people. Our objective was to describe the association between CYP2C9 and CYP2C19 genetic polymorphisms and adverse reactions induced by antiseizure medications among Peruvian patients with epilepsy. Methods: A descriptive observational study was conducted on Peruvian patients with epilepsy. Non-probability, non-randomized, purposive sampling was carried out through consecutive inclusion. Genomic DNA was obtained from venous blood samples. Genotypes were determined by real-time PCR using specific TaqMan probes to identify the alleles of interest. Results: In total, 89 Peruvian patients with epilepsy were recruited at the Alberto Sabogal Sologuren National H...

The presence of CYP1A1 allelic variants and deletion of the glutathione S-transferase GSTM1 gene, and their imbalance, have been suggested as risk factors for inducing colorectal cancer (CRCa). The objective was to identify CYP1A1 and GSTM1 and evaluate the association with the risk of developing colorectal cancer in a sample of cases and controls from Lima, Peru. This was a case-control study of CYP1A1 and GSTM1 genes in 50 samples from patients diagnosed with colorectal cancer and 50 samples from controls without cancer, using the PCR-based restriction fragment length polymorphism method. A significant risk of developing CRCa was found in the following groups: GSTM1*0 carriers with no history of smoking or family history of cancer (OR = 3.56, 95% CI 1.43–8.88, p = 0.0060); GSTM1*0 with family history of cancer without smoking (OR = 2.81, 95% CI 0.35–22.49, p = 0.3280); GSTM1*0 exac...